Berry Wealth Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Berry Wealth Group's ABBV Position: Q2 2026 in Review
Berry Wealth Group reduced its AbbVie (ABBV) stake by 20% in Q2 2026, selling an estimated $48.2K and leaving 881 shares worth $222K. The position accounts for 0.71% of the portfolio, ranked #30.
Berry Wealth Group first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.12M in Q2 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Berry Wealth Group held 881 shares of AbbVie worth $222K as of Q2 2026.
- Berry Wealth Group sold 224 AbbVie shares in Q2 2026, an estimated $48.2K.
- AbbVie made up 0.71% of Berry Wealth Group's portfolio in Q2 2026, its #30 holding.
- Berry Wealth Group first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
- Berry Wealth Group's AbbVie position peaked at $3.12M in Q2 2025.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Berry Wealth Group's 13F filing for Q2 2026, filed 12 Aug 2026.